nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing research and development of anti-infectives for children with a focus on antiretroviral therapy: A clinical development perspective
|
Buchanan, Ann M. |
|
|
64 |
4 |
p. |
artikel |
2 |
A phase I clinical study: Evaluation of safety, tolerability, and population pharmacokinetic-pharmacodynamic target attainment analysis of etimicin sulfate among healthy chinese participants
|
Zhao, Xue |
|
|
64 |
4 |
p. |
artikel |
3 |
A physiologically based pharmacokinetic model of voriconazole in human CNS—Integrating time-dependent inhibition of CYP3A4, genetic polymorphisms of CYP2C19 and possible transporter mechanisms
|
Dong, Liuhan |
|
|
64 |
4 |
p. |
artikel |
4 |
Dual therapy based on co-formulated darunavir/ritonavir plus lamivudine for initial therapy of HIV infection: The ANDES randomized controlled trial
|
Figueroa, M.I. |
|
|
64 |
4 |
p. |
artikel |
5 |
Gut colonization with antibiotic-resistant Escherichia coli pathobionts leads to disease severity in ulcerative colitis
|
Yadav, Asha |
|
|
64 |
4 |
p. |
artikel |
6 |
Host immunomodulation strategies to combat pandemic-associated antimicrobial-resistant secondary bacterial infections
|
Raghavan, Srimathi |
|
|
64 |
4 |
p. |
artikel |
7 |
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo
|
Liu, Haifeng |
|
|
64 |
4 |
p. |
artikel |
8 |
Improvement in high-density lipoprotein cholesterol in people with HIV who switched from a tenofovir alafenamide-containing regimen to cabotegravir plus rilpivirine
|
Muccini, Camilla |
|
|
64 |
4 |
p. |
artikel |
9 |
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis
|
Kuhlin, Johanna |
|
|
64 |
4 |
p. |
artikel |
10 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
64 |
4 |
p. |
artikel |
11 |
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria
|
Majdi, Chaimae |
|
|
64 |
4 |
p. |
artikel |
12 |
Is there evidence on the optimal duration of aminoglycoside therapy in β-lactam/aminoglycoside combination regimens used for the treatment of gram-negative bacterial infections? A systematic review
|
Wale, Yalew M. |
|
|
64 |
4 |
p. |
artikel |
13 |
Mediastinitis caused by an NDM-1 Escherichia coli in a child with Dacron Sano shunt after pulmonary atresia with ventricular septal defect surgery treated with combination of aztreonam-avibactam
|
Cousin, Vladimir L. |
|
|
64 |
4 |
p. |
artikel |
14 |
Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams
|
Rolain, Hunter |
|
|
64 |
4 |
p. |
artikel |
15 |
Neisseria gonorrhoeae ST-1901 in Rio de Janeiro from 2006 to 2022: Phylogeny and antimicrobial resistance evolution of a well-succeeded pathogen
|
de Medeiros, Raphael Cavalcante |
|
|
64 |
4 |
p. |
artikel |
16 |
Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia
|
Ding, Peili |
|
|
64 |
4 |
p. |
artikel |
17 |
Pharmacodynamics of taniborbactam in combination with cefepime studied in an in vitro model of infection
|
Noel, A.R. |
|
|
64 |
4 |
p. |
artikel |
18 |
Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patients
|
Schatz, Lea Marie |
|
|
64 |
4 |
p. |
artikel |
19 |
Reduced mortality with antimicrobial stewardship guided by BioFire FilmArray Blood Culture Identification 2 panel in critically ill patients with bloodstream infection: A retrospective propensity score-matched study
|
Tseng, How‑Yang |
|
|
64 |
4 |
p. |
artikel |
20 |
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data
|
Liu, Yangxi |
|
|
64 |
4 |
p. |
artikel |
21 |
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade
|
Wan, Tsai-Wen |
|
|
64 |
4 |
p. |
artikel |
22 |
The impact of extracorporeal support on antimicrobial pharmacokinetics in critically ill neonatal and paediatric patients: A systematic review
|
Cree, Michele L. |
|
|
64 |
4 |
p. |
artikel |
23 |
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division
|
Degiacomi, Giulia |
|
|
64 |
4 |
p. |
artikel |
24 |
Title Page & Editorial Board
|
|
|
|
64 |
4 |
p. |
artikel |
25 |
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans, coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity
|
Peng, Xinyuan |
|
|
64 |
4 |
p. |
artikel |